Cacho-Díaz B, Reyes-Soto G, Monroy-Sosa A, Lorenzana-Mendoza, NA, Olvera-Manzanilla E, Rodríguez-Orozco J, Villanueva-Xolio A, Herrera-Gómez Á, Granados-García M

Language: Spanish
References: 16
Page: 13-20
PDF size: 125.81 Kb.

ABSTRACT

Introduction: Cancer is one of the leading causes of death in our population. There is little information about neurological manifestations related to cancer and its treatment.
Objective: To describe the neurological manifestations in patients with cancer.
Methods: From January 2010 to December 2014 a database was created from patients with cancer, required a neuro-oncological assessment at a referral cancer center.
Results: 17,092 reasons for neurooncological consultation are described. Neoplasms most frequently associated with neurological manifestations were: breast cancer, hematologic malignancies, primary CNS tumors, lung cancer and gynecological malignancies. The most frequent neurological manifestations were: neuromuscular disease (including neuropathy), CNS metastasis, primary headaches, seizures, stroke and primary neurological tumors.
Conclusion: It is important that neurologists, physicians and those involved in the management of patients with cancer recognize and get to know the neurological complications.

REFERENCES

1. Meneses-García A R-GL, Beltrán-Ortega A, Sánchez-Cervantes F, Tapia-Conyer R, Mohar A. Principales neoplasias malignas en México y su distribución geográfica (1993-2002). Revista de Investigación Clínica. 2012;64(4):322-9.

2. Cacho-Díaz B. Síndromes neurológicos paraneoplásicos (Parte I): abordaje y características generales. Rev Mex Neuroci. 2010;11(2):150-9.

3. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66. PubMed PMID: 11602373.

4. Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol. 1992 Mar;31(3):268-73. PubMed PMID: 1637135. Epub 1992/03/01. eng.

5. Giglio P, Gilbert MR. Neurologic complications of cancer and its treatment. Curr Oncol Rep. 2010 Jan;12(1):50-9. PubMed PMID: 20425608. Pubmed Central PMCID: 3637950.

6. Khasraw M, Posner JB. Neurological complications of systemic cancer. Lancet Neurol. 2010 Dec;9(12):1214-27. PubMed PMID: 21087743.

7. Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes JM, et al. Neurological complications of breast cancer: A prospective cohort study. Breast. 2015 Oct;24(5):582-7. PubMed PMID: 26096894.

8. Abrey LE, Dalmau JO. Neurologic complications of ovarian carcinoma. Cancer. 1999 Jan 1;85(1):127-33. PubMed PMID: 9921984.

9. Ariad S, Geffen DB, Yanai-Inbar I, Zalmanov S, Piura B. Myasthenia gravis associated with malignant mixed Mullerian tumor of the uterus. Gynecol Oncol. 1997 Mar;64(3):510-5. PubMed PMID: 9062162.

10. Saphner T, Gallion HH, Van Nagell JR, Kryscio R, Patchell RA. Neurologic complications of cervical cancer. A review of 2261 cases. Cancer. 1989 Sep 1;64(5):1147-51. PubMed PMID: 2667751. Epub 1989/09/01. eng.

11. Blade J, Rosinol L. Complications of multiple myeloma. Hematol Oncol Clin North Am. 2007 Dec;21(6):1231-46, xi. PubMed PMID: 17996596. Epub 2007/11/13. eng.

12. Recht L, Mrugala M. Neurologic complications of hematologic neoplasms. Neurol Clin. 2003 Feb;21(1):87-105. PubMed PMID: 12690646.

13. Antoine JC, Camdessanche JP. Peripheral nervous system involvement in patients with cancer. Lancet Neurol. 2007 Jan;6(1):75-86. PubMed PMID: 17166804. Epub 2006/12/15. eng.

14. Cacho-Díaz B, Estañol-Vidal B. Síndromes neurológicos paraneoplásicos (Parte II): Sistema nervioso periférico y autonómico. Rev Mex Neuroci. 2010;11(3):226-33.

15. Nolan CP, DeAngelis LM. Neurologic complications of chemotherapy and radiation therapy. Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):429-51. PubMed PMID: 25837905.

16. Cacho-Díaz B, Alegría-Loyola M, Sierra del Río M, Gonzále-Aguilar A, Cuevas-Ramos D, Reyes-Soto G, et al. Neurología elemental. First ed. Barcelona, España: Elsevier; 2014. 362 p.